# Synyi.AI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/synyi-ai

- Industry: Software
- Headquarters: Shanghai, China
- Website: www.synyi.com
- Total disclosed funding: $198M
- Latest round: Series E (Jul 9, 2021)
- Investors on record: 14

## About

Established in 2016 and based in Shanghai, China, Synyi.AI is a comprehensive solution provider for smart hospitals, focusing on providing new infrastructure solutions for hospitals. It has branch offices in Changchun, Zhongshan, and Hefei. The company has acquired more than 200 patents and software copyright certificates. Clinical Research Center of Shanghai Jiao Tong University School of Medicine, Medical Informatics Center of Peking University, and Fudan University, have cooperated with the company. Zhang Shaodian, the founder, is a Vice Chairman of Shanghai Pudong New Area Federation of Industry and Commerce. In July 2024, Synyi.AI closed a strategic investment.

The company provides artificial intelligence solutions such as clinical medical records, imaging reports, and genetic testing reports based on Chinese medical natural language processing, machine learning and other technologies. Specific products include physical examination health management system, hospital-wide scientific research platform, medical big data platform, hospital-wide clinical knowledge base and disease intelligent management and control platform.

The company generates revenue by developing and providing medical data analysis and management platform.

## Funding rounds

- Series E, Jul 9, 2021, $77M — IDG Capital, Sharewin Investment, Longmen Investment
- Series D, Dec 22, 2020, $61M — China International Capital Corporation, Tencent Investment, Sunshine Insurance Group
- Series C, Jul 3, 2019, $36M — Tencent Investment, Shanghai Jianyi Private Equity Fund Management
- Series B, Nov 8, 2018 — Xiang He Capital
- Series B, May 2, 2018, $16M — Hong Shan, ZhenFund, Jiyuan Capital
- Series A, Apr 6, 2017, $8M — Hong Shan, Zhongdian Shurong Investment Management
- Angel, Nov 1, 2016 — CRCM, ZhenFund, Shulan (Hangzhou) Hospital

## Investors

- CRCM (https://capitalatlas.ai/funds/crcm) — Angel
- ZhenFund (https://capitalatlas.ai/funds/zhenfund) — Angel, Series B
- Shulan (Hangzhou) Hospital — Angel
- Hong Shan — Series A, Series B
- Zhongdian Shurong Investment Management (https://capitalatlas.ai/funds/zhongdian-shurong-investment-management) — Series A
- Jiyuan Capital (https://capitalatlas.ai/funds/jiyuan-capital) — Series B
- Xiang He Capital (https://capitalatlas.ai/funds/xiang-he-capital) — Series B
- Tencent Investment — Series C, Series D
- Shanghai Jianyi Private Equity Fund Management (https://capitalatlas.ai/funds/shanghai-jianyi-private-equity-fund-management) — Series C
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series D
- Sunshine Insurance Group — Series D
- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Series E
- Sharewin Investment (https://capitalatlas.ai/funds/sharewin-investment) — Series E
- Longmen Investment (https://capitalatlas.ai/funds/longmen-investment) — Series E